Brugada syndrome and arrhythmogenic cardiomyopathy: overlapping disorders of the connexome?

Europace

Institute of Molecular and Clinical Sciences, St. George's University of London, Cranmer Terrace, London SW17 0RE, UK.

Published: May 2021

AI Article Synopsis

  • Arrhythmogenic cardiomyopathy (ACM) and Brugada syndrome (BrS) are genetic conditions that increase the risk of heart rhythm problems and sudden cardiac death.
  • Various studies suggest that there are overlapping features between ACM and BrS, particularly in their underlying mechanisms.
  • Recent research highlights potential similarities in the structure of cardiac cell connections, which may support the idea that these two diseases could be variants within the same disease spectrum.

Article Abstract

Arrhythmogenic cardiomyopathy (ACM) and Brugada syndrome (BrS) are inherited diseases characterized by an increased risk for arrhythmias and sudden cardiac death. Possible overlap between the two was suggested soon after the description of BrS. Since then, various studies focusing on different aspects have been published pointing to similar findings in the two diseases. More recent findings on the structure of the cardiac cell-cell junctions may unite the pathophysiology of both diseases and give further evidence to the theory that they may in part be variants of the same disease spectrum. In this review, we aim to summarize the studies indicating the pathophysiological, genetic, structural, and electrophysiological overlap between ACM and BrS.

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euaa277DOI Listing

Publication Analysis

Top Keywords

brugada syndrome
8
arrhythmogenic cardiomyopathy
8
syndrome arrhythmogenic
4
cardiomyopathy overlapping
4
overlapping disorders
4
disorders connexome?
4
connexome? arrhythmogenic
4
cardiomyopathy acm
4
acm brugada
4
syndrome brs
4

Similar Publications

Clinical association of the SCN5A c.2302A>G variant (p.Ile768Val) with Brugada syndrome.

Rev Esp Cardiol (Engl Ed)

January 2025

Departamento de Salud, Universidad de Los Lagos, Osorno, Chile; Programa de Investigación en Biomedicina y Biotecnología en Salud, Departamento de Salud, Universidad de Los Lagos, Osorno, Chile. Electronic address:

View Article and Find Full Text PDF

Routine Electrical Substrate Mapping in Brugada Syndrome: Is Direct Epicardial Assessment Truly Necessary?

JACC Clin Electrophysiol

January 2025

Fondazione Toscana "Gabriele Monasterio," Pisa, Italy; Scuola Superiore Sant'Anna, Pisa, Italy. Electronic address:

View Article and Find Full Text PDF

Background: Superior caval vein obstruction is a rare complication of endocardial pacing lead implantation that can result in a right to left shunt.

Case Summary: A 3-year-old child with type 2 Brugada syndrome presented with mild cyanosis post-endocardial pacing implantation due to evolutionary right superior caval vein obstruction. This obstruction resulted in a right to left shunt across a previously unrecognized patent levo-atrial cardinal vein associated with partial anomalous pulmonary venous drainage.

View Article and Find Full Text PDF

Inappropriate Shocks in Brugada Syndrome Patients With a Subcutaneous Implantable Cardioverter Defibrillator.

Pacing Clin Electrophysiol

January 2025

Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Background: This study aimed to compare inappropriate shock (IAS) rates between subcutaneous implantable cardioverter-defibrillator (S-ICD) and transvenous ICD (TV-ICD) in Brugada syndrome (BrS) patients and identify risk factors for IAS in S-ICD use.

Methods: We enrolled consecutive patients with BrS who underwent ICD implantation between 2013 and 2023. Data on clinical characteristics, S-ICD screening test data, and IAS occurrence were retrospectively analyzed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!